1-6 of 6
David M. Vail
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

Amy K. LeBlanc, Christina N. Mazcko, Aswini Cherukuri, Erika P. Berger, William C. Kisseberth, Megan E. Brown, Susan E. Lana, Kristen Weishaar, Brian K. Flesner, Jeffrey N. Bryan, David M. Vail, Jenna H. Burton, Jennifer L. Willcox, Anthony J. Mutsaers, J. Paul Woods, Nicole C. Northrup, Corey Saba, Kaitlin M. Curran, Haley Leeper, Heather Wilson-Robles, Brandan G. Wustefeld-Janssens, Stephanie Lindley, Annette N. Smith, Nikolaos Dervisis, Shawna Klahn, Mary Lynn Higginbotham, Raelene M. Wouda, Erika Krick, Jennifer A. Mahoney, Cheryl A. London, Lisa G. Barber, Cheryl E. Balkman, Angela L. McCleary-Wheeler, Steven E. Suter, Olya Martin, Antonella Borgatti, Kristine Burgess, Michael O. Childress, Janean L. Fidel, Sara D. Allstadt, Daniel L. Gustafson, Laura E. Selmic, Chand Khanna, Timothy M. Fan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (11): 3005–3016.
https://doi.org/10.1158/1078-0432.CCR-21-0315
Published: 01 June 2021
View article titled, Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
Open the PDF for Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs in another window
Includes: Supplementary data
Journal Articles

Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation

Douglas H. Thamm, Ilene D. Kurzman, Mike A. Clark, E.J. Ehrhart, III, Susan L. Kraft, Daniel L. Gustafson, David M. Vail
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1498–1508.
https://doi.org/10.1158/1078-0432.CCR-09-2804
Published: 28 February 2010
View article titled, Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation
Open the PDF for Preclinical Investigation of PEGylated Tumor Necrosis Factor α in Dogs with Spontaneous Tumors: Phase I Evaluation in another window
Journal Articles

Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma

David M. Vail, Douglas H. Thamm, Hans Reiser, Adrian S. Ray, Grushenka H.I. Wolfgang, William J. Watkins, Darius Babusis, Ilana N. Henne, Michael J. Hawkins, Ilene D. Kurzman, Robert Jeraj, Matt Vanderhoek, Susan Plaza, Christie Anderson, Mackenzie A. Wessel, Cecilia Robat, Jessica Lawrence, Daniel B. Tumas
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (10): 3503–3510.
https://doi.org/10.1158/1078-0432.CCR-08-3113
Published: 18 May 2009
View article titled, Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma
Open the PDF for Assessment of GS-9219 in a Pet Dog Model of Non-Hodgkin's Lymphoma in another window
Journal Articles

Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation

Douglas H. Thamm, Ilene D. Kurzman, Ivan King, Zujin Li, Mario Sznol, Richard R. Dubielzig, David M. Vail, E. Gregory MacEwen
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4827–4834.
https://doi.org/10.1158/1078-0432.CCR-04-2510
Published: 06 July 2005
View article titled, Systemic Administration of an Attenuated, Tumor-Targeting <em>Salmonella typhimurium</em> to Dogs with Spontaneous Neoplasia: Phase I Evaluation
Open the PDF for Systemic Administration of an Attenuated, Tumor-Targeting <em>Salmonella typhimurium</em> to Dogs with Spontaneous Neoplasia: Phase I Evaluation in another window
Journal Articles

Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor

E. Gregory MacEwen, Ilene D. Kurzman, David M. Vail, Richard R. Dubielzig, Karen Everlith, Bruce R. Madewell, Carlos O. Rodriguez, Jr., Brenda Phillips, Courtney H. Zwahlen, Joyce Obradovich, Robert C. Rosenthal, Leslie E. Fox, Mona Rosenberg, Carolyn Henry, Janean Fidel
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (12): 4249–4258.
Published: 01 December 1999
View article titled, Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor
Open the PDF for Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor in another window
Journal Articles

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

A. Elizabeth Hershey, Ilene D. Kurzman, Lisa J. Forrest, Cheryl A. Bohling, Michael Stonerook, Michael E. Placke, Anthony R. Imondi, David M. Vail
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (9): 2653–2659.
Published: 01 September 1999
View article titled, Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
Open the PDF for Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model in another window